Drug profile · INN
chlorthalidone
CHLORTHALIDONE
chlorthalidone (CHLORTHALIDONE) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — chlorthalidone
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 3
- Programs
- 5
- Data quality
- 0.89
Quick answer
chlorthalidone (CHLORTHALIDONE) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Thiazide-sensitive sodium-chloride cotransporter inhibitor
Primary target: Solute carrier family 12 member 3
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is chlorthalidone?
chlorthalidone (CHLORTHALIDONE) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for chlorthalidone?
CHLORTHALIDONE is a marketed brand name for chlorthalidone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of chlorthalidone?
chlorthalidone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.